These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33411030)

  • 1. Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas.
    Fernandez-Cuesta L; Mangiante L; Alcala N; Foll M
    Virchows Arch; 2021 Jan; 478(1):73-80. PubMed ID: 33411030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleural mesothelioma classification update.
    Beasley MB; Galateau-Salle F; Dacic S
    Virchows Arch; 2021 Jan; 478(1):59-72. PubMed ID: 33475835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural mesothelioma classification-update and challenges.
    Dacic S
    Mod Pathol; 2022 Jan; 35(Suppl 1):51-56. PubMed ID: 34465883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance of immunohistochemistry markers for malignant pleural mesothelioma diagnosis and subtypes. A systematic review and meta-analysis.
    Parra-Medina R; Castañeda-González JP; Chaves-Cabezas V; Alzate JP; Chaves JJ
    Pathol Res Pract; 2024 May; 257():155276. PubMed ID: 38603842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics and Functional Genomics of Malignant Pleural Mesothelioma.
    Cakiroglu E; Senturk S
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition.
    de Reyniès A; Jaurand MC; Renier A; Couchy G; Hysi I; Elarouci N; Galateau-Sallé F; Copin MC; Hofman P; Cazes A; Andujar P; Imbeaud S; Petel F; Pairon JC; Le Pimpec-Barthes F; Zucman-Rossi J; Jean D
    Clin Cancer Res; 2014 Mar; 20(5):1323-34. PubMed ID: 24443521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma.
    Kinoshita Y; Hamasaki M; Matsumoto S; Yoshimura M; Sato A; Tsujimura T; Kamei T; Kawahara K; Nabeshima K
    Pathol Int; 2020 Sep; 70(9):671-679. PubMed ID: 32542810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis.
    Bruno R; Alì G; Giannini R; Proietti A; Lucchi M; Chella A; Melfi F; Mussi A; Fontanini G
    Oncotarget; 2017 Jan; 8(2):2758-2770. PubMed ID: 27835874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma.
    Meiller C; Montagne F; Hirsch TZ; Caruso S; de Wolf J; Bayard Q; Assié JB; Meunier L; Blum Y; Quetel L; Gibault L; Pintilie E; Badoual C; Humez S; Galateau-Sallé F; Copin MC; Letouzé E; Scherpereel A; Zucman-Rossi J; Le Pimpec-Barthes F; Jaurand MC; Jean D
    Genome Med; 2021 Jul; 13(1):113. PubMed ID: 34261524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular heterogeneity of malignant pleural mesotheliomas].
    Tranchant R; Montagne F; Jaurand MC; Jean D
    Bull Cancer; 2018 Jan; 105(1):35-45. PubMed ID: 29277245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleural neoplastic pathology.
    Karpathiou G; Stefanou D; Froudarakis ME
    Respir Med; 2015 Aug; 109(8):931-43. PubMed ID: 26048082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.
    Opitz I; Bueno R; Lim E; Pass H; Pastorino U; Boeri M; Rocco G;
    Eur J Cardiothorac Surg; 2014 Oct; 46(4):602-6. PubMed ID: 24623168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of several biomarkers for the patients with malignant pleural mesothelioma.
    Liu H; Wu L; Ji K; Wang W
    Tumour Biol; 2015 Sep; 36(10):7375-84. PubMed ID: 26361957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics.
    Bertero L; Righi L; Collemi G; Koelsche C; Hou Y; Stichel D; Schrimpf D; Flucke U; Petersen I; Vokuhl C; Fröhling S; Bironzo P; Scagliotti GV; Cassoni P; Papotti M; von Deimling A
    J Mol Diagn; 2021 Jul; 23(7):834-846. PubMed ID: 33887463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical feature of diagnostic challenging cases for pleural biopsy in patient with malignant pleural mesothelioma.
    Hashimoto M; Sato A; Kuroda A; Nakamura A; Nakamichi T; Kondo N; Yuki M; Nabeshima K; Tsujimura T; Hasegawa S
    Gen Thorac Cardiovasc Surg; 2020 Aug; 68(8):820-827. PubMed ID: 31981139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma.
    Martínez-Rivera V; Negrete-García MC; Ávila-Moreno F; Ortiz-Quintero B
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
    Mangiante L; Alcala N; Sexton-Oates A; Di Genova A; Gonzalez-Perez A; Khandekar A; Bergstrom EN; Kim J; Liu X; Blazquez-Encinas R; Giacobi C; Le Stang N; Boyault S; Cuenin C; Tabone-Eglinger S; Damiola F; Voegele C; Ardin M; Michallet MC; Soudade L; Delhomme TM; Poret A; Brevet M; Copin MC; Giusiano-Courcambeck S; Damotte D; Girard C; Hofman V; Hofman P; Mouroux J; Cohen C; Lacomme S; Mazieres J; de Montpreville VT; Perrin C; Planchard G; Rousseau N; Rouquette I; Sagan C; Scherpereel A; Thivolet F; Vignaud JM; Jean D; Ilg AGS; Olaso R; Meyer V; Boland-Auge A; Deleuze JF; Altmuller J; Nuernberg P; Ibáñez-Costa A; Castaño JP; Lantuejoul S; Ghantous A; Maussion C; Courtiol P; Hernandez-Vargas H; Caux C; Girard N; Lopez-Bigas N; Alexandrov LB; Galateau-Salle F; Foll M; Fernandez-Cuesta L
    Nat Genet; 2023 Apr; 55(4):607-618. PubMed ID: 36928603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.
    Greillier L; Tounsi A; Berenguer-Daizé C; Dussault N; Delfino C; Benyahia Z; Cayol M; Mabrouk K; Garcia S; Martin PM; Barlesi F; Ouafik L
    J Thorac Oncol; 2016 Jan; 11(1):94-107. PubMed ID: 26762744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Molecular Basis of Malignant Pleural Mesothelioma.
    Wadowski B; De Rienzo A; Bueno R
    Thorac Surg Clin; 2020 Nov; 30(4):383-393. PubMed ID: 33012428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific genetic variants can be detected in circulating cell-free DNA of malignant pleural mesothelioma patients.
    Hylebos M; Op de Beeck K; Pauwels P; Zwaenepoel K; van Meerbeeck JP; Van Camp G
    Lung Cancer; 2018 Oct; 124():19-22. PubMed ID: 30268460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.